Crealta Pharmaceuticals, LLC

500 West Silver Spring Drive Suite K-200,
Glendale, Wisconsin 53217
United States,
(414) 847-6346
www.crealtapharma.com

Crealta is a specialty pharmaceutical company focused on innovative therapeutics designed to improve patient outcomes. The company, which has two marketed medicines KRYSTEXXA and MIGERGOT, was formed to acquire, develop and market specialty medicines with a focus on select physician specialties.

M&A Summary

Buy vs Sell

Year '13 '14 '15 '16 '17 T
Buy (0.2/yr) # 1 - - - - 1
vol $120M $120M
Sell (0.2/yr) # - 1 - - - 1
  2

Top M&A Advisors

Financial Deals
Join to Access.
Legal Deals
Join to Access.

Deal Values

Buy # TOTAL
> $1B Sign-up to View
$100M to $1B Sign-up to View
< $100M Sign-up to View
TOTAL Sign-up to View
Largest Savient Pharmaceuticals, Inc.
$120M (2013-12-11)
Sell # Total
> $1B Sign-up to View
$100M to $1B Sign-up to View
< $100M Sign-up to View
Total Sign-up to View

Crealta Pharmaceuticals was acquired by Horizon Pharma on December 11, 2015.

Crealta Pharmaceuticals has acquired 1 company of its own, including 1 in the last 5 years. It has also divested 1 asset.

Crealta Pharmaceuticals’ largest acquisition to date was in 2013, when it acquired Savient Pharmaceuticals for $120M. Crealta Pharmaceuticals has acquired in 1 US state. The Company’s most targeted sectors include life science (100%).

When analyzing the life science sector as a whole, according to Mergr, in the last 3 years, there are 420 life science companies that have made at least 1 acquisition, 25 have acquired at least 5 companies, and 4 have acquired more than 10 companies. The most prolific strategic life science acquirer over the past 3 years is Eurofins Scientific SA, with 24 acquisitions. The most prolific private equity acquirer in the life science sector over the past 3 years is Ampersand Capital Partners with 4 platform acquisitions.

Join Mergr and gain access to Crealta Pharmaceuticals’ M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.


What's Mergr?

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 3.1K Private Equity Firms
  • 110K M&A Transactions
  • 120K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 2.7K M&A Advisors
    (Investment Banks and Law Firms)
  • 38K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.